RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 96 filers reported holding RECRO PHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $487,000 | -23.2% | 300,427 | -62.5% | 0.00% | 0.0% |
Q2 2022 | $634,000 | -58.9% | 800,661 | -6.8% | 0.00% | -66.7% |
Q1 2022 | $1,544,000 | -1.3% | 859,039 | -6.2% | 0.00% | +50.0% |
Q4 2021 | $1,564,000 | +56.1% | 915,745 | +87.9% | 0.00% | 0.0% |
Q3 2021 | $1,002,000 | -21.5% | 487,270 | -12.0% | 0.00% | 0.0% |
Q2 2021 | $1,276,000 | -19.5% | 553,592 | -2.7% | 0.00% | -33.3% |
Q1 2021 | $1,586,000 | -1.7% | 569,022 | +0.3% | 0.00% | 0.0% |
Q4 2020 | $1,614,000 | +1693.3% | 567,258 | +1200.0% | 0.00% | – |
Q3 2020 | $90,000 | -89.1% | 43,634 | -76.1% | 0.00% | -100.0% |
Q2 2020 | $828,000 | +114.5% | 182,406 | +284.5% | 0.00% | +100.0% |
Q1 2020 | $386,000 | -81.1% | 47,438 | -57.4% | 0.00% | -75.0% |
Q4 2019 | $2,043,000 | +391.1% | 111,459 | +196.9% | 0.00% | +300.0% |
Q3 2019 | $416,000 | +766.7% | 37,544 | +674.4% | 0.00% | – |
Q2 2019 | $48,000 | +29.7% | 4,848 | -34.9% | 0.00% | – |
Q2 2018 | $37,000 | +117.6% | 7,443 | +396.2% | 0.00% | – |
Q1 2018 | $17,000 | – | 1,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Athyrium Capital Management, LP | 2,202,420 | $6,145,000 | 3.11% |
Samjo Capital LLC | 560,000 | $1,562,000 | 1.16% |
MAK CAPITAL ONE LLC | 1,224,264 | $3,416,000 | 0.81% |
Cowen Prime Services LLC | 470,500 | $1,313,000 | 0.50% |
Portolan Capital Management | 1,957,283 | $5,461,000 | 0.43% |
Parkman Healthcare Partners LLC | 601,967 | $1,679,000 | 0.39% |
Rubric Capital Management LP | 1,076,587 | $3,004,000 | 0.18% |
Frontier Wealth Management LLC | 49,112 | $2,142,000 | 0.16% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 466,992 | $1,303,000 | 0.16% |
AWM Investment Company, Inc. | 391,304 | $1,092,000 | 0.12% |